LANTERN PHARMA INC. (LTRN)
Lantern Pharma Invites Investors, Analysts & Shareholders to Experience the Future of Drug Discovery via a Live Demo of withZeta.ai — the Worlds First Multi-Agentic Co-Scientist for Rare Cancers — 8:30 AM Eastern, April 9, 2026
📈 **POSITIVE** • High confidence analysis (88%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business